Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 12.45
+0.17 (1.38%)
At close: Feb 3, 2026
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 26.85 billion as of February 3, 2026. Its market cap has increased by 39.46% in one year.
Market Cap
26.85B
Enterprise Value
23.83B
Revenue
6.50B
Ranking
n/a
PE Ratio
1.10
Stock Price
12.45
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 26.85B, an increase of 1,171.25%. That is a compound annual growth rate of 28.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 26.85B | -1.13% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 57.77B |
| Shanghai Junshi Biosciences | 36.42B |
| TransThera Sciences (Nanjing) | 32.98B |
| Biocytogen Pharmaceuticals (Beijing) | 32.27B |
| Shanghai Henlius Biotech | 31.14B |
| Duality Biotherapeutics | 29.49B |
| InnoCare Pharma | 23.18B |
| Ascentage Pharma Group International | 17.70B |